David Gibson
McDermott Will & Emery UK LLPLauded for advice that ‘balances the risks and benefits of any given approach clearly’, McDermott Will & Emery UK LLP is active across regulatory matters such as medical device certifications and transactional work spanning M&A, IP transfers and growth capital investments. Sharon Lamb heads up the team and has a far-reaching practice spanning commercial, regulatory and transactional expertise. Hamid Yunis is a key contact for private equity transactions. Michal Berkner, who joined from Cooley (UK) LLP in February 2024, further bolsters the team’s transactional capacities and counts takeover defences, corporate governance, and joint ventures among her practice strengths. David Gibson and Bella North are further key names to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Their understanding of the environment in which their clients are working is exceptional, and their advice balances the risks and benefits of any given approach clearly. They are responsive and flexible. ’
‘Sharon Lamb is the best partner I have ever worked with and her support of navigating some very challenging situations has been above and beyond expectations. Her contribution to our organisation is more than just her legal excellence as she also supports another important aspect of our work in the healthtech sector such as diversity and inclusion.’
‘Good broad knowledge of the life sciences area - with the ability to span US and Europe.’
‘I've worked with Gary Howes for years and find him an extremely pragmatic, knowledgeable, commercial lawyer.’
‘Extremely high quality and commercial advice.’
‘Sharon Lamb is an excellent partner.’
‘Exceptional knowledge of the healthcare sector, regulation and legislation. Forensic approach to research, preparation and delivery. A team that embraces diversity. Well-networked within healthcare.’
‘Gary Howes is a great client leader.’
Key clients
- Novartis Groupe France SAS
- Zura Bio Limited
- Vesey Street Capital Partners
- Fortius/Affidea
- ProductLife Group Limited
- I.Q. Endoscope
- Supporting Wounded Veterans Limited
- Ampersand Capital Partners
Work highlights
- Advised Novartis Groupe France SAS on the sale of the company CellforCure and its cell and gene therapy development and production site in Les Ulis, France, to Seqens SAS.
- Advised Vesey Street Capital Partners (“VSCP”), a New-York based sector specialist PE firm investing in pharma services companies on the acquisition of the Inceptua group of companies (“Inceptua”) (“Inceptua Acquisition”) and the investment, by the primary seller and Inceptua management in the equity structure going forward (“Inceptua Investment”).
- Advised Zura Bio Limited on several transactions including, on its licence and collaboration agreement with Eli Lilly & Company, whereby Zura acquired rights to potential autoimmune disease drug tibulizumab (renamed ZB-106) from Lilly.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Sharon Lamb
McDermott Will & Emery UK LLPPractice head
The lawyer(s) leading their teams.
Sharon Lamb